GlassScriptPhysician profile
Nathan Chad Weaver
NPI 1386064863
$7,364.41
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,619 · 2020: $2,298 · 2021: $100 · 2022: $54.19 · 2023: $2,128 · 2024: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,299 · Food and Beverage: $994.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,298.99 |
| Food and Beverage | $994.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,143.84 | 2019-2024 | Journey, Polarstem, Ri Hip Navigation |
| Goode Surgical INC | $2,150.65 | 2020 | |
| Medical Device Business Services, INC. | $939.95 | 2019 | |
| Medacta USA, INC. | $410.54 | 2019 | |
| Zimmer Biomet Holdings, INC. | $364.95 | 2019 | |
| Depuy Synthes Sales INC. | $94.80 | 2019-2022 | |
| Organogenesis INC. | $65.17 | 2020-2023 | Puraply |
| Bioventus LLC | $64.42 | 2021-2023 | Exogen Ultrasound Bone Healing System |
| Molnlycke Health Care US, LLC | $21.30 | 2019 | |
| Medline Industries LP | $16.70 | 2019 | |
| Convatec INC. | $15.65 | 2023 | |
| Stimwave Technologies Incorporated | $15.41 | 2021 | |
| Endo Pharmaceuticals INC. | $15.26 | 2019 | |
| Ethicon US, LLC | $14.59 | 2020 | |
| Amgen INC. | $14.39 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $11.39 | 2020 | |
| Biocomposites INC | $5.40 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Weaver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.